As we age, our natural production of glutathione, the body's master antioxidant, declines, leaving us more vulnerable to fatigue, toxins, and oxidative stress.* But you can fight back
The most effective balance of GLP-1, GIP, and glucagon activity may differ by patient phenotype, diabetes status, degree of obesity, hepatic steatosis, baseline insulin resistance, and tolerability profile
IL-1 binds to the interleukin-1 receptor (IL-1R) to activate myeloid differentiation primary response 88 (MyD88) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B)
Its major evidence-based and investigational research areas include: Reduction of visceral adipose tissue Endogenous GH, IGF-1, and IGFBP-3 activation Reduced waist circumference and trunk fat Modest increases in lean body mass Triglyceride and lipid-related changes Hepatic-fat research Exploratory skeletal-muscle composition findings Changes in body composition without substantial overall weight loss The strongest evidence applies to reducing excess abdominal fat in adults with HIV-associated lipodystrophy